Loading...
OTCMRMHI
Market cap492kUSD
Dec 23, Last price  
1.26USD
1D
29.64%
IPO
2,824.42%
Name

Peak Pharmaceuticals Inc

Chart & Performance

D1W1MN
OTCM:RMHI chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
Net income
CFO

Profile

Peak Pharmaceuticals, Inc. operates as a bio­pharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THC­free, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.
IPO date
May 17, 2010
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

No data to show